Involvement of apoptosis and interferon-γ in murine toxoplasmosis

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 9, 2001, Pages 2031-2036

  De Fen Shen, ^a   Matteson, D M ^a   Tuaillon, N ^a   Suedekum, B K ^a   Buggage, R R ^a   Chan, C C ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE; NITRITE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYST; DISEASE ASSOCIATION; EYE INFLAMMATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; FAS LIGAND PROTEIN; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; NITRITES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TOXOPLASMOSIS, CEREBRAL; TOXOPLASMOSIS, OCULAR;

EID: 0034907952     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Toxoplasmic encephalitis in AIDS patients and experimental models for study of the disease and its treatment
2. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome
3. Congenital toxoplasmosis: Systematic review of evidence of efficacy of treatment in pregnancy
4. Changing patterns of uveitis
5. Toxoplasmosis
6. Ocular toxoplasmosis
7. An unusually high prevalence of ocular toxoplasmosis in southern Brazil
8. Reconsidering the pathogenesis of ocular toxoplasmosis
9. Toxoplasma gondii: Acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma
10. Functional and quantitative analysis of splenic T cell immune responses following oral toxoplasma gondii infection in mice
11. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis
12. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation
13. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice
14. Interferon-gamma: The major mediator of resistance against Toxoplasma gondii
15. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice
16. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis
17. Protective role of nitric oxide in ocular toxoplasmosis
18. Social controls on cell survival and cell death
19. Mechanisms and genes of cellular suicide
20. Is the induction of apoptosis the mechanism of the protective effects of TNF alpha in helminth infection?
21. The regulation of apoptosis by microbial pathogens
22. The Fas death factor
23. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice
24. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation
25. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
26. Cytokines and apoptotic molecules in experimental melanin-protein induced uveitis (EMIU) and experimental autoimmune uveoretinitis (EAU)
27. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
28. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer
29. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production
30. Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens
31. Fas ligand-induced apoptosis as a mechanism of immune privilege
32. Apoptosis in patients with posterior uveitis
33. The role of FasL-induced apoptosis in immune privilege
34. Effect of aqueous humor on apoptosis of inflammatory cell types
35. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis
36. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
37. Apoptosis and autoimmunity: Two sides to the coin
38. Death receptors: Signaling and modulation
39. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii
40. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine
41. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon
42. Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis
43. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis
44. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha
45. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation
46. Macrophage interactions in toxoplasmosis
47. Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C